Psoriasis Treatment Market By Treatment Type (Systemic Treatments {Biologics, Oral Medication [Methotrexate, Cyclosporine, Acitretin]}, Topical Treatments {Corticosteroids, Vitamin D Analogs, Retinoids, Calcineurin Inhibitors}, Phototherapy {UVB Therapy, PUVA (Psoralen + UVA), Excimer Laser}), By Disease Severity (Mild, Moderate, Severe), By Route of Administration (Topical, Oral, Injectable, Intravenous), and By Distribution Channel (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Oct 2024 | Report ID: MI1189 | 225 Pages
Report Coverage:
By Treatment Type
- Systemic Treatments
- Biologics
- Oral Medication
- Methotrexate
- Cyclosporine
- Acitretin
- Topical Treatments
- Corticosteroids
- Vitamin D Analogs
- Retinoids
- Calcineurin Inhibitors
- Phototherapy
- UVB Therapy
- PUVA (Psoralen + UVA)
- Excimer Laser
By Disease Severity
- Mild
- Moderate
- Severe
By Route of Administration
- Topical
- Oral
- Injectable
- Intravenous
By Distribution Channel
- Hospitals
- Specialty Clinics
- Retail Pharmacies
- Online Pharmacies
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- AbbVie
- Amgen
- Johnson & Johnson
- Novartis
- Pfizer
- Bristol-Myers Squibb
- Eli Lilly
- GSK
- Dermira
- Incyte
- Sanofi
- Celgene
- AstraZeneca
- UCB
- Mylan
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.